Published in Leuk Lymphoma on May 01, 2002
The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood (2010) 5.95
Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia. N Engl J Med (2015) 3.42
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. J Hematol Oncol (2010) 2.94
Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica (2006) 2.75
Critical Role of STAT5 transcription factor tetramerization for cytokine responses and normal immune function. Immunity (2012) 2.16
High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia. J Clin Oncol (2012) 2.13
Nuclear miRNA regulates the mitochondrial genome in the heart. Circ Res (2012) 1.95
Ibrutinib and novel BTK inhibitors in clinical development. J Hematol Oncol (2013) 1.92
MEK and the inhibitors: from bench to bedside. J Hematol Oncol (2013) 1.90
Fetal mouse phthalate exposure shows that Gonocyte multinucleation is not associated with decreased testicular testosterone. Toxicol Sci (2007) 1.75
Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I Trial. J Clin Oncol (2012) 1.58
Phase I and pharmacokinetic study of Triapine, a potent ribonucleotide reductase inhibitor, in adults with advanced hematologic malignancies. Leuk Res (2007) 1.57
Oral sapacitabine for the treatment of acute myeloid leukaemia in elderly patients: a randomised phase 2 study. Lancet Oncol (2012) 1.54
Current management and novel agents for malignant melanoma. J Hematol Oncol (2012) 1.53
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application. Biomark Res (2013) 1.43
Sweet's syndrome with CML cell infiltration of the skin in a patient with chronic-phase CML while taking Imatinib Mesylate. Leuk Res (2004) 1.42
First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib. J Hematol Oncol (2010) 1.40
Induction of ATM activation, histone H2AX phosphorylation and apoptosis by etoposide: relation to cell cycle phase. Cell Cycle (2007) 1.34
Novel CD20 monoclonal antibodies for lymphoma therapy. J Hematol Oncol (2012) 1.30
Reversal in multidrug resistance by magnetic nanoparticle of Fe3O4 loaded with adriamycin and tetrandrine in K562/A02 leukemic cells. Int J Nanomedicine (2008) 1.29
New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer. J Hematol Oncol (2009) 1.24
Current management and prognostic features for gastrointestinal stromal tumor (GIST). Exp Hematol Oncol (2012) 1.23
p38 mitogen-activated protein kinase plays an inhibitory role in hepatic lipogenesis. J Biol Chem (2006) 1.23
Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights. J Hematol Oncol (2010) 1.18
STAT inhibitors for cancer therapy. J Hematol Oncol (2013) 1.16
Recent advances and novel agents for gastrointestinal stromal tumor (GIST). J Hematol Oncol (2012) 1.16
Treatment-induced oxidative stress and cellular antioxidant capacity determine response to bortezomib in mantle cell lymphoma. Clin Cancer Res (2011) 1.14
Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors. J Clin Invest (2010) 1.14
B-Raf and the inhibitors: from bench to bedside. J Hematol Oncol (2013) 1.14
Ingestion of an isothiocyanate metabolite from cruciferous vegetables inhibits growth of human prostate cancer cell xenografts by apoptosis and cell cycle arrest. Carcinogenesis (2004) 1.13
Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention. Int J Oncol (2004) 1.12
Dietary nitrate and nitrite modulate blood and organ nitrite and the cellular ischemic stress response. Free Radic Biol Med (2009) 1.12
Phenylhexyl isothiocyanate inhibits histone deacetylases and remodels chromatins to induce growth arrest in human leukemia cells. Int J Oncol (2006) 1.11
Response to histone deacetylase inhibition of novel PML/RARalpha mutants detected in retinoic acid-resistant APL cells. Blood (2002) 1.06
Microarray-based characterization of a colony assay used to investigate endothelial progenitor cells and relevance to endothelial function in humans. Arterioscler Thromb Vasc Biol (2009) 0.99
A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome. J Hematol Oncol (2011) 0.99
Testicular gene expression profiling following prepubertal rat mono-(2-ethylhexyl) phthalate exposure suggests a common initial genetic response at fetal and prepubertal ages. Toxicol Sci (2006) 0.99
P-loop mutations and novel therapeutic approaches for imatinib failures in chronic myeloid leukemia. J Hematol Oncol (2008) 0.95
Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis. Exp Hematol Oncol (2012) 0.94
A Phase II study of Bcl-2 antisense (oblimersen sodium) combined with gemtuzumab ozogamicin in older patients with acute myeloid leukemia in first relapse. Leuk Res (2006) 0.93
Sox4 cooperates with PU.1 haploinsufficiency in murine myeloid leukemia. Blood (2011) 0.92
Side effects related to cancer treatment: CASE 2. Splenic rupture following pegfilgrastim. J Clin Oncol (2005) 0.92
Severe toxicity of skin rash, fever and diarrhea associated with imatinib: case report and review of skin toxicities associated with tyrosine kinase inhibitors. Drug Des Devel Ther (2009) 0.91
A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide. J Hematol Oncol (2012) 0.91
CD146+ T lymphocytes are increased in both the peripheral circulation and in the synovial effusions of patients with various musculoskeletal diseases and display pro-inflammatory gene profiles. Cytometry B Clin Cytom (2010) 0.89
Phenylhexyl isothiocyanate has dual function as histone deacetylase inhibitor and hypomethylating agent and can inhibit myeloma cell growth by targeting critical pathways. J Hematol Oncol (2008) 0.89
Phase I study of temozolomide in relapsed/refractory acute leukemia. J Clin Oncol (2002) 0.86
Addition of AEG35156 XIAP antisense oligonucleotide in reinduction chemotherapy does not improve remission rates in patients with primary refractory acute myeloid leukemia in a randomized phase II study. Clin Lymphoma Myeloma Leuk (2011) 0.84
Severe toxicity following induction chemotherapy for acute myelogenous leukemia in a patient with Werner's syndrome. Leuk Lymphoma (2005) 0.84
The phenylhexyl isothiocyanate induces apoptosis and inhibits leukemia cell growth in vivo. Oncol Rep (2006) 0.84
DNA damage response as a biomarker in treatment of leukemias. Cell Cycle (2009) 0.84
Palladium-catalyzed allylic alkylation of simple ketones with allylic alcohols and its mechanistic study. Angew Chem Int Ed Engl (2014) 0.84
miR-222 contributes to sex-dimorphic cardiac eNOS expression via ets-1. Physiol Genomics (2013) 0.84
t(8;14;18): a 3-way chromosome translocation in two patients with Burkitt's lymphoma/leukemia. Mol Cancer (2007) 0.83
Treatment of adults with acute lymphoblastic leukemia: do the specifics of the regimen matter?: Results from a prospective randomized trial. Cancer (2012) 0.82
High fat diet reduces the expression of glutathione peroxidase 3 in mouse prostate. Prostate (2011) 0.82
Efficient palladium-catalyzed asymmetric allylic alkylation of ketones and aldehydes. Org Biomol Chem (2011) 0.80
PET scan-positive cat scratch disease in a patient with T cell lymphoblastic lymphoma. Leuk Res (2005) 0.80
T-cryptantigen (TCA) activation in sever pneumonia complicated with multiple organ failure. Transfus Apher Sci (2010) 0.79
Acute promyelocytic leukemia with tetraploid karyotype: first report in the Western hemisphere and update of previous reports. Leuk Res (2011) 0.79
C-N bond cleavage of allylic amines via hydrogen bond activation with alcohol solvents in Pd-catalyzed allylic alkylation of carbonyl compounds. J Am Chem Soc (2011) 0.79
Deficient histone acetylation in acute leukemia and the correction by an isothiocyanate. Acta Haematol (2009) 0.79
Novel biomarkers for diagnosis, prognosis, targeted therapy and clinical trials. Biomark Res (2013) 0.78
[Coblation-assisting uvulopalatopharyngoplasty combining coblation-channeling of the tongue for patients with severe OSAHS]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2012) 0.78
Novel influenza A (H1N1) in patients with hematologic malignancies. J Clin Oncol (2009) 0.77
High-dose chemotherapy with autologous stem cell rescue in stage IIIB inflammatory breast cancer. Anticancer Res (2008) 0.77
[Modulation of histone acetylation and induction of apoptosis in SMMC-7721 cells by phenylhexyl isothiocyanate]. Zhonghua Zhong Liu Za Zhi (2010) 0.76
Hydrogen-bond-activated palladium-catalyzed allylic alkylation via allylic alkyl ethers: challenging leaving groups. Org Lett (2014) 0.76
Very late relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation. Leuk Res (2009) 0.76
Prospective evaluation of 2009 H1N1 influenza A in patients admitted with fever to an oncology unit. Infect Control Hosp Epidemiol (2011) 0.76
t(3;9;22) 3-way chromosome translocation in chronic myeloid leukemia is associated with poor prognosis. Cancer Invest (2009) 0.76
Journal of hematology & oncology: a journal open to all. J Hematol Oncol (2008) 0.75
Treatment of brain tumors. N Engl J Med (2005) 0.75
Sweet fruit from a poisonous kiss. J Hematol Oncol (2010) 0.75
Phenotypic and functional characterization of a mouse model of targeted Pig-a deletion in hematopoietic cells. Haematologica (2009) 0.75
P-stereogenic PNP pincer-Pd catalyzed intramolecular hydroamination of amino-1,3-dienes. Org Biomol Chem (2015) 0.75
Asymmetric hydrogenation of β-amino ketones with the bimetallic complex RuPHOX-Ru as the chiral catalyst. Org Biomol Chem (2013) 0.75
The synthesis of chiral β-aryl-α,β-unsaturated amino alcohols via a Pd-catalyzed asymmetric allylic amination. Org Biomol Chem (2013) 0.75
[Coblation-channelling for the tongue]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2014) 0.75
[Low-temperature plasma assisted via mouth for surgery treating styloid process syndrome]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2012) 0.75
[Revaluvation of UPPP and the pharynx in patients with snoring anatomy]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2015) 0.75
Asymmetric tandem reactions of N-sulfonylimines and α,β-unsaturated aldehydes: an alternative reaction pathway to that of using saturated aldehydes. Chem Commun (Camb) (2014) 0.75
[Coblation for benign hyperplasia of tongue base under endoscope]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2009) 0.75
[Lingual thyroglossal duct cyst treatment by low temperature coblation on endoscope]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2014) 0.75
Asymmetric domino reaction of cyclic N-sulfonylimines and simple aldehydes with trans-perhydroindolic acid as an organocatalyst. Org Lett (2014) 0.75
[Preliminary clinical investigation of coblation-assisted functional endoscopic sinus surgery for chronic sinusitis and nasal polyps]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2011) 0.75
Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock. Front Med (2014) 0.75
Palladium-catalyzed asymmetric hydrogenation of α-acyloxy-1-arylethanones. Angew Chem Int Ed Engl (2013) 0.75
Publish, not perish: Introducing Experimental Hematology & Oncology. Exp Hematol Oncol (2012) 0.75
[Clinical observation of coblation under endoscopy on epiglottis cyst]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2014) 0.75